CORRECTION: Agilon Health Sees Q3 Sales $1.445B-$1.475B vs $1.415B Est
Agilon Health (NYSE:AGL) sees Q3 sales of $1.445 billion-$1.475 billion vs $1.415 billion analyst estimate.
Agilon Health says their Q3 sales will be a bit higher than what experts thought they'd make. This shows the company is doing slightly better than people expected, which can be a small positive sign about how healthy the business is.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.